ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A comparison of accurate automatic hippocampal segmentation methods

Zandifar, Azar; Fonov, Vladimir; Coupe, Pierrick; Pruessner, Jens; Collins, D. Louis*
NeuroImage2017-7-15DOI: 10.1016/j.neuroimage.2017.04.018
30被引11阅读
引用收藏
分享

摘要

The hippocampus is one of the first brain structures affected by Alzheimer's disease (AD). While many automatic methods for hippocampal segmentation exist, few studies have compared them on the same data. In this study, we compare four fully automated hippocampal segmentation methods in terms of their conformity with manual segmentation and their ability to be used as an AD biomarker in clinical settings. We also apply error correction to the four automatic segmentation methods, and complete a comprehensive validation to investigate differences between the methods. The effect size and classification performance is measured for AD versus normal control (NC) groups and for stable mild cognitive impairment (sMCI) versus progressive mild cognitive impairment (pMCI) groups. Our study shows that the nonlinear patch-based segmentation method with error correction is the most accurate automatic segmentation method and yields the most conformity with manual segmentation (kappa = 0.894). The largest effect size between AD versus NC and sMCI versus pMCI is produced by FreeSurfer with error correction. We further show that, using only hippocampal volume, age, and sex as features, the area under the receiver operating characteristic curve reaches up to 0.8813 for AD versus NC and 0.6451 for sMCI versus pMCI. However, the automatic segmentation methods are not significantly different in their performance.

学科与关键词

关键词
Hippocampal segmentationAlzheimer's diseaseDice's kappaCohen's dArea under receiver operating characteristic curve
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
NeuroImage
发表日期
2017-07-15
卷期
第 155 卷
页码
383-393
DOI
10.1016/j.neuroimage.2017.04.018
语言
ENGLISH
期刊等级
Q1
成果收录
SCIE
资助标注
Canadian Institutes of Health Research [MOP-111169]; les Fonds de Research Sante Quebec Pfizer Innovation fund [25262]; NSERC CREATE [4140438 - 2012]; Famille Louise Andre Charron; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai, Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development, LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; Canada Foundation for Innovation (CFI); ministere de l'Economie, de la Science et de l'Innovation du Quebec (MESI); Fonds de recherche du Quebec - Nature et technologies (FRQ-NT)

作者

  • Z

    Zandifar, Azar (第一作者)

  • F

    Fonov, Vladimir

查看全部 5 位作者收起作者
  • C

    Coupe, Pierrick

  • P

    Pruessner, Jens

  • C

    Collins, D. Louis (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417